Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New antibiotics from BTG

Jan. 16, 1997

3DP and ViroPharma establish drug discovery collaboration

Jan. 15, 1997

Xoma expands pivotal Neuprex trials

Jan. 15, 1997

Antifungal agent described by Roussel Morishita

Jan. 15, 1997

FDA to review AmBisome NDA

Jan. 14, 1997

More oxazolidinone antimicrobial agents under study at P&U

Jan. 14, 1997

Merck & Co. discloses novel antifungal agents

Jan. 14, 1997

The Liposome Company's Abelcet receives marketing approval in 14th country

Jan. 13, 1997

Sequus' Amphotec earns 19th marketing approval

Jan. 10, 1997

Merck & Co. describes avermectin analogue

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...